RecallHawk
Class II Recall

The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole catheter designed for the inf

Micro Therapeutics, Inc.

Summary

The FDA issued a Class II for The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen by Micro Therapeutics, Inc.. Reason: European version of microcatheter were distributed within US which contain a different "Indications for Use"..

Details

Source

Device Recall

External ID

Z-1252-2024

Action Date

2024-03-13

Status

Ongoing

Category

device

Product Description

The Apollo Onyx Delivery Microcatheter (AOMC) is a DMSO-compatible, single-lumen, end hole catheter designed for the infusion of the Onyx liquid embolic system (LES). The catheter has a semi-rigid proximal shaft and a highly flexible distal shaft to facilitate the advancement of the catheter in the anatomy. The proximal end of the catheter incorporates a standard Luer adapter to facilitate the attachment of accessories. The outer diameter surface of the catheter is hydrophilically coated to increase lubricity. The AOMC is designed to facilitate catheter retrieval in the event the catheter becomes entrapped within the vasculature. The distal section of the catheter incorporates a detachment zone that allows detachment of the distal tip when the force required to extract the catheter exceeds the force to detach the tip. The catheter has two radiopaque marker bands to visualize the position of the catheter and the detach zone area, one proximal to the detach zone and one at the distal end of the catheter.

Lot/Code Info: UDI: 00763000311438/ Lot # B510757, B593510, B610689

Quantity Affected: 82 units

Reason for Recall

European version of microcatheter were distributed within US which contain a different "Indications for Use".

Distribution

US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KS, MA, MD, MI, MO, NC, ND, NE, NV, NY, OH, OK, PA, SC, TN, TX, UT, VA, WA, WI.

Type: Voluntary: Firm initiated

Recall Initiated: 2024-01-11

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 225 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Micro Therapeutics, Inc. has 9 FDA actions in our database, including 9 recalls.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Micro Therapeutics, Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Micro Therapeutics, Inc. have FDA actions?

Micro Therapeutics, Inc. has 9 FDA actions in our database, including 9 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-1252-2024" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions